Concentra Biosciences, LLC - Insider Non-Derivative Transactions at Jounce Therapeutics, Inc. (JNCE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 3, 2023, Concentra Biosciences, LLC's relationship to Jounce Therapeutics, Inc. (JNCE) is TenPercentOwner, and currently has 10,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JNCE insiders.
Data Source: SEC.
Concentra Biosciences, LLC - Insider Non-Derivative Transactions at JNCE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 4, 2023 | J -- (Common Stock) | 10000 | 9737.7 | 10000 |